Free shipping on all orders over $ 500

INT-777

Cat. No. M9055

All AbMole products are for research use only, cannot be used for human consumption.

INT-777 Structure
Synonym:

S-EMCA

Size Price Availability Quantity
1mg USD 165  USD165 In stock
2mg USD 245  USD245 In stock
5mg USD 400  USD400 In stock
10mg USD 550  USD550 In stock
25mg USD 900  USD900 In stock
50mg USD 1350  USD1350 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

INT-777 is a novel potent and selective TGR5 agonist. INT-777 (3 μM) increases ATP production in the human enteroendocrine cell line NCI-H716 in a cAMP-dependent manner. INT-777 (10 μM) lowers Isc and increases TEER when added on the serosal side of seromuscular stripped distal colon segments.

In vivo, INT-777 (1 μM/min/kg, p.o.) has a potent choleretic effect, prevents carboxyl CoA activation and subsequent conjugation, thereby favoring its cholehepatic shunt pathway with a ductular absorption and a potent choleretic effect in HF-fed TGR5-Tg male mice. INT-777 (30 mg/kg/day, p.o.) increases energy expenditure and reduces hepatic steatosis and obesity upon high fat feeding, and improves insulin sensitivity, in TGR5-Tg mice.

Chemical Information
Molecular Weight 450.65
Formula C27H46O5
CAS Number 1199796-29-6
Form Solid
Solubility (25°C) DMSO: ≥ 25 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Duboc H, et al. Neurogastroenterol Motil. Reduction of epithelial secretion in male rat distal colonic mucosa by bile acid receptor TGR5 agonist, INT-777: role of submucosal neurons.

[2] Pellicciari R, et al. J Med Chem. Discovery of 6alpha-ethyl-23(S)-methylcholic acid (S-EMCA, INT-777) as a potent and selective agonist for the TGR5 receptor, a novel target for diabesity.

Related GPCR19/TGR5 Products
Ursodeoxycholic acid sodium

Ursodeoxycholic acid (Ursodeoxycholate) sodium is a secondary bile acid issued from the transformation of (cheno)deoxycholic acid by intestinal bacteria, acting as a key regulator of the intestinal barrier integrity and essential for lipid metabolism.

SB756050

SB756050 is a selective TGR5 agonist. SB756050 has the potential for type 2 diabetes treatment.

Deoxycholic acid sodium salt

Deoxycholic acid sodium salt is a bile acid and a by-product of intestinal metabolism, Deoxycholic acid sodium salt can activate the G protein-coupled bile acid receptor TGR5.

SBI-115

SBI-115 is a TGR5 (GPCR19) antagonist, it decreases hepatic cystogenesis with polycystic liver diseases via inhibiting TGR5.

BAR 502

BAR502 is a dual agonist of FXR and GPBAR1 with IC50 values of 2 μM and 0.4 μM, respectively.

  Catalog
Abmole Inhibitor Catalog




Keywords: INT-777, S-EMCA supplier, GPCR19/TGR5, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.